Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02452749 · ClinicalTrials.gov registry record · NA
Prospective Safety and Tolerability Assessment of a Cardiovascular Health Dietary Supplement
A NA study, sponsored by National University of Natural Medicine.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02452749 is a NA study that has completed, run by National University of Natural Medicine. The registered enrollment target is 30 participants.
The verdict
NCT02452749, a NA study, has completed, sponsored by National University of Natural Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This single-arm, open-label study will assess the safety and tolerability of one daily tablet of a commercially available cardiovascular health dietary supplement by questionnaire and blood markers in adults with borderline to mild hypertension over a 6 month period. Although the cardiovascular health dietary supplement being investigated has been on the market for over 20 years, prospective safety data and blood markers of end organ function have not previously been reported.
Interventions
- DIETARY_SUPPLEMENT Cardiovascular health dietary supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-05-01 |
| Est. Completion | 2017-07-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02452749
The ClinicalTrials.gov registry entry for NCT02452749 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National University of Natural Medicine, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiovascular health dietary supplement is the first listed.
NCT02452749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02452749 about?
NCT02452749 is a clinical study titled "Prospective Safety and Tolerability Assessment of a Cardiovascular Health Dietary Supplement". This single-arm, open-label study will assess the safety and tolerability of one daily tablet of a commercially available cardiovascular health dietary supplement by questionnaire and blood markers in adults with borderline to mild hypertension over a 6 month period. Although the cardiovascular heal...
What is the current status of trial NCT02452749?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2015-05-01. Estimated completion is 2017-07-28.
What interventions are being tested in trial NCT02452749?
The interventions under investigation include: Cardiovascular health dietary supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02452749?
This trial is sponsored by National University of Natural Medicine, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.